Marlborough, MA, February 1, 2018 – Proveris Scientific Corporation today announced Chip Leveille has been named President, effective immediately. As President, Leveille will have responsibility for all areas of corporate operations including Sales, Marketing, Business Development, Support, Product Development, Quality, Operations, Finance and Human Resources. He will report directly to Chief Executive Officer Dino Farina.

Proveris Scientific is a leading provider of services and technology to advance the science of nasal and inhaled drug delivery. “We are proud to name Chip Leveille as President of Proveris Scientific as we are entering an exciting phase,” said Dino Farina, Founder and CEO. “With his extensive commercial experience, Chip will drive the company in accelerated product, application and technology development. Key initiatives include improving how spray and aerosol drug delivery products are brought to market globally, and evaluating opportunities for expansion into new industries.”

Leveille brings extensive experience and insight into sales, marketing, product research and development, operations, corporate development, and regulatory affairs, based on his past senior leadership positions which includes a successful executive consulting business, senior executive and commercial leadership positions in biopharmaceutical technology providers including Affymetrix, BioScale, Helicos, and Zymark Corporation.

“I am very excited to lead Proveris in our next stage of growth,” says Leveille, “Proveris has very strong customer relationships, proven technologies and an untapped potential to provide new and innovative products that will help our customers bring the best performing spray and aerosol products to the global market.”

About Proveris Scientific:

Proveris Scientific Corporation advances the science of nasal and inhaled drug delivery by providing leading technology in spray performance measurement, unrivaled accuracy in automated actuation, and expertise in drug-device optimization. Since its founding in 1995, the company has accelerated the development the top spray drug products and has deployed its systems at more than 100 pharmaceutical development and manufacturing sites around the globe. Proveris’s systems are the industry standard and are used by the FDA, CFDA, and the pharmaceutical industry to generate submission-ready data. Proveris is certified to ISO 9001:2008 by TUV Rheinland of North America and has more than 20 patents on its technology issued in United States, Europe, and Asia. For more information, please visit